Market Overview

Global Respiratory Drugs Market 2018-2022 | High Cost of Respiratory Disease Management to Boost Demand | Technavio

Share:

Technavio
analysts forecast the global respiratory drugs market to grow at a CAGR
of close to 6% during the forecast period, according to their
latest market research report. The growth momentum of the market is
expected to accelerate in the year-over-year growth.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190102005304/en/

Technavio analysts forecast the global respiratory drugs market to grow at a CAGR of close to 6% by  ...

Technavio analysts forecast the global respiratory drugs market to grow at a CAGR of close to 6% by 2022. (Graphic: Business Wire)

The high cost of respiratory disease management is one of the major
trends being witnessed in the global
respiratory drugs market 2018-2022
. Respiratory diseases are a
huge burden globally in terms of direct health services costs and
indirect costs related to prescribed respiratory drugs. The high cost of
respiratory disease management has led organizations such as the Lung
Foundation Australia to demand support and funding from the government
to reduce the cost burden of respiratory drugs on patients. Also, the
British Lung Foundation and the British Thoracic Society opine for
cost-effective approaches of respiratory disease management.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

According to Technavio analysts, one of the key factors contributing to
the growth of the global respiratory drugs market is an increase in the
incidence and prevalence of respiratory disorders:

Global respiratory drugs market: Increase in
incidence and prevalence of respiratory disorders

Respiratory disorders are the major cause of mortality and disease
burden globally. Respiratory disorders such as COPD, asthma, acute
respiratory infections are on the rise. In Germany, between 2009 and
2016, the highest incident rates of acute respiratory infection were
recorded, and in the US, nearly 6.7% of all deaths were due to chronic
respiratory diseases.

According to a senior analyst at Technavio, "COPD affects more than
200 million people globally. Around 235 million people globally live
with asthma; the number of cases has increased in the past three decades
in both developing and developed countries. Respiratory diseases account
for more than four million deaths in developing countries. Also,
pneumonia accounts for 18% of deaths in children under the age of five."

Global respiratory drugs market: Segmentation
analysis

The global respiratory drugs market research report provides market
segmentation by type of respiratory disease (asthma, COPD, allergic
rhinitis, cystic fibrosis, and other respiratory disorders) and by
region (the Americas, EMEA, and APAC). It provides an in-depth analysis
of the prominent factors influencing the market, including drivers,
opportunities, trends, and industry-specific challenges.

The Americas held the largest share of the market in 2017, accounting
for more than 49% share. It was followed by EMEA and APAC respectively.
Factors such as the increase in the prevalence of respiratory diseases
and improved knowledge about the prevention of respiratory diseases
drive the market in the Americas.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com